Slider

Agenda

9:00 am - 10:00 am     Session 1: Principles for the Assessment of Dysarthria

10:10 am - 11:10 am   Session 2: The SLP's Role in the Management of Parkinson's Disease

11:20 am - 12:20 pm   Session 3: AAC Management for Clients with ALS

Registration (Coming Soon)

$20 for ArSHA Members
$40 for Non-members
* Attendance to all three sessions is required to receive CE credit

Sessions

Session 1:  Principles for the Assessment of Dysarthria - 1 hour

Meghan Darling-White, PhD, CCC-SLP

This presentation will focus on best practices for perceptual assessment of dysarthria. It will include methods for assessing the speech subsystems of articulation, resonance, phonation and respiration, as well as how the findings of the perceptual assessment link to impairments of these subsystems.

Session 2:  The SLP's Role in the Management of Parkinson's Disease – 1 hour

Tara Chay, MA, CCC-SLP, ATP, MSCS

This presentation will address the speech-language pathologist’s role in the management of Parkinson's disease, focusing on salient characteristic impairments associated with the disease, how to use these to develop a treatment plan and outcome measures, and relevant standardized treatment protocols for this population.

Session 3AAC Management for Clients with ALS – 1 hour

Kelly Ingram, MS, CCC-SLP

This presentation will review literature on types of ALS and related Motor Neuron Diseases as well as the staging of intervention in dysarthria. Alternative communication options will be discussed for each level and resources that provide current options for low tech and high tech will be reviewed. Lastly, current funding guidelines and paperwork for high tech AAC will be presented.

Learner Outcomes

At the end of this presentation, participants will be able to:

  1. Describe best practices of a perceptual assessment for individuals with dysarthria.
  2. Describe the link between findings from a perceptual assessment and potential impairment of the speech subsystem.
  3. Identify two-three characteristic impairments associated with Parkinson's disease to inform treatment plan and outcome measures.
  4. Identify two standardized treatment protocols designed to treat patients with Parkinson's disease.
  5. Explain use of a staging model for dysarthria in order to determine what type of intervention is needed as speech deteriorates as a symptom of ALS.
  6. Identify at least three websites that provide up-to-date high tech equipment options, low cost speech apps and AAC funding assistance so they can stay current with technology and requirement changes in order to meet the needs of their clients.

Presenter Information

Meghan Darling-White, PhD, CCC-SLP, is an assistant professor in the speech, language and hearing sciences department of the University of Arizona. She earned her PhD from Purdue University and completed a postdoctoral fellowship at the Waisman Center at the University of Wisconsin-Madison. Her long-term research goal is to develop and validate theoretically driven, data-based interventions that have an impact on functional speech production skills in individuals with motor speech disorders. Specifically, she is interested in understanding the relationship between respiratory behavior during speech production and speech production skills, like speech naturalness and intelligibility. This requires a multi-faceted approach that includes the collection and analysis of kinematic, acoustic and perceptual data. Dr. Darling-White has extensive experience working with both developmental and degenerative motor speech disorders. Her current work involves children with cerebral palsy and children with down syndrome.

Tara Chay, MA, CCC-SLP, ATP, MSCS, is a speech-language pathologist and the rehabilitation program coordinator in the Outpatient Rehabilitation Center at Barrow Neurological Institute. Ms. Chay's expertise includes the evaluation and treatment of individuals with Parkinson's disease, progressive supranuclear palsy, multi-system atrophy, corticobasal degeneration, and multiple sclerosis. She is certified in the LSVT-LOUD and SPEAK OUT!® treatment protocols and has training in the use of sEMG techniques for the treatment of dysphagia. She is an active member of the Barrow Adaptive Technologies task force and the Rehabilitation Engineering and Assistive Technology Society of North America (RESNA).

Kelly Ingram, MS, CCC-SLP, is a clinical professor and program director in the MS communication disorders program at Arizona State University. She has a clinical interest in supervision, adult neurogenic disorders and child phonology. For the past 12 years she has provided speech-language pathology services and student supervision as part of a multidisciplinary team at a neuromuscular clinic where she assists clients with the management of communication and swallowing as a result of ALS.

This course is offered for up to .3 ASHA CEUs (Various levels; Professional area).
Presenter Disclosures